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Purpose: To identify genes underlying autosomal recessive retinitis pigmentosa (ARRP) by homozygosity mapping.
Methods: Families with ARRP were recruited after complete ophthalmic evaluation of all members and diagnosis of RP
by predefined criteria. Genomic DNA from affected members of 26 families was genotyped on Illumina single nucleotide
polymorphism (SNP) 6.0 K arrays with standard procedures. Genotypes were evaluated for homozygous regions that were
common and concordant between affected members of each family. The genes mapping to homozygous intervals within
these  families  were  screened  for  pathogenic  changes  with  PCR  amplification  and  sequencing  of  coding  regions.
Cosegegration of sequence changes with disease was determined within each pedigree, and each variation was tested for
presence in 100 unrelated normal controls.
Results: A genome-wide scan for homozygosity showed homozygous regions harboring the tubby like protein 1 gene
(TULP1; chromosome 6) in one family, the nuclear receptor subfamily 2, group E, member 3 gene (NR2E3; chromosome
15) in three families, and the membrane frizzled-related protein gene (MFRP; chromosome 11) in one family. Screening
of the three genes in the respective families revealed homozygous disease-causing mutations in three families. These
included a missense mutation in TULP1, a deletion-cum-insertion in NR2E3, and a single base deletion in MFRP. Patients
from all three families had a rod-cone type of dystrophy with night blindness initially. The NR2E3 and MFRP genes were
associated with fundus features atypical of RP.
Conclusions: This study shows involvement of the TULP1, NR2E3, and MFRP genes in ARRP in Indian cases. Genome-
wide screening with SNP arrays followed by a prioritized candidate gene evaluation is useful in identifying genes in these
patients.
Retinitis pigmentosa (RP) is a group of hereditary retinal
degenerations involving loss of retinal photoreceptor cells and
leading to irreversible visual loss or blindness. The age of
onset of RP is usually within the first or second decade, and
it is a progressive disorder with a high degree of clinical
heterogeneity. Though a range of different yet overlapping
phenotypes comprise RP, the characteristic features are initial
symptoms of diminished night and/or day vision, progressive
loss  of  visual  acuity  and  visual  fields,  extinguished
electroretinographic (ERG) responses, and fundus changes,
including  arterial  attenuation,  disc  pallor,  retinal  pigment
epithelium (RPE) atrophy, and the presence of intraretinal
pigmentary deposits. Mutations in more than 60 genes are
known for autosomal and X-linked forms of non-syndromic
RP alone (RetNet). Autosomal recessive RP (ARRP) accounts
for one-third or more of the total cases of RP in different
populations  [1]  and  has  the  highest  degree  of  genetic
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heterogeneity  among  the  various  forms,  with  34  genes
reported so far.
Autozygosity or homozygosity screening to identify loci
for recessive disorders has been recognized as a powerful and
effective approach especially in the presence of inbreeding
and  consanguinity  [2].  Application  of  this  method  on  a
genome-wide scale has been facilitated by the use of SNP
arrays to detect regions of homozygosity, with subsequent
candidate  gene  analysis  [3].  The  main  advantages  of  this
approach are that it can be applied in small families with even
a  single  to  a  few  affected  individuals  that  would  not  be
significant enough for linkage analysis and, in the case of a
highly heterogeneous disorder such as RP, can enable the
search for disease genes to be narrowed to a few or more
potential loci that can be evaluated individually for known and
novel candidates. The prevalence of RP varies in different
parts of the world, ranging from about 1 in 4,000 to 1 in 1,000
[4-6]. Blindness due to RP is estimated to occur in 1 in 1,000
of  the  population  of  Andhra  Pradesh  in  south  India  [7].
Knowledge  of  causative  genes  in  each  population  can
facilitate the design of screening and counseling strategies for
patients, and serve to direct or develop appropriate therapeutic
approaches that are genotype-dependent. There is relatively
little  knowledge  of  genes  underlying  RP  in  Indian
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1165populations.  We  performed  a  genome-wide  homozygosity
screening on 6.0K SNP arrays, and herein we report novel
mutations in known RP genes detected in three families with
autosomal recessive RP (ARRP).
METHODS
Patient  recruitment:  Families  were  recruited  based  on
ophthalmic evaluation of probands and all available family
members,  including  parents  and  siblings.  All  subjects
underwent a comprehensive examination, including visual
acuity testing, indirect ophthalmoscopy, ERGs, and visual
fields. Diagnosis of RP was made according to predefined
criteria, which have been previously described [8]. Pedigree
information  including  the  presence  and  nature  of
consanguinity was obtained in each family. Those with a
pattern suggestive of autosomal recessive inheritance were
included. The protocol for the study was approved by the
Institutional Review Board. Informed consent was obtained
from all subjects for participation in the study and collection
of  blood  samples.  Peripheral  blood  was  collected  by
venipuncture in EDTA-coated vaccutainer tubes and stored at
−20 °C until extraction of DNA.
Single  nucleotide  polymorphism  arrays  and  genotyping:
Genomic  DNA  was  isolated  from  blood  leukocytes  with
standard methods. DNA was quantified using the PicoGreen
assay (Invitrogen Life Technologies, Carlsbad, CA). DNA
from two affected members from each family was genotyped
on the Illumina SNP 6.0K genotyping array (Illumina Inc.,
San Diego, CA). Hybridization to the array was performed
according to the Infinium II assay protocol using reagents
from Illumina. Briefly, genomic DNA was denatured, and
subjected to whole genome amplification. Amplified DNA
was fragmented and hybridized on the Infinium Array for 24
h under appropriate conditions. Excess unhybridized DNA
was washed, and single base extension was performed on
hybridized  primers  with  labeled  nucleotides.  Arrays  were
stained, washed, and scanned on the Illumina Bead Array
Reader.  SNP  genotypes  were  obtained  using  the  Illumina
Bead Studio v 2.0 genotyping module. The genotypes call
rates obtained were around 98%. SNP data were arranged
according  to  genomic  position  and  copied  into  an  Excel
(Microsoft  Corporation,  Redmond,  WA)  spreadsheet,  and
runs  of  autozygosity  were  detected  using  an  Excel-based
program created for this purpose. Regions of homozygous
SNPs with at least ten or more consecutive SNPs were selected
for further evaluation. Consecutive and homozygous SNPs
common to two affected siblings within each family were
selected, and the ten largest such regions were shortlisted to
identify  candidate  genes.  In  the  initial  screening  phrase,
regions that were 5 Mb or more were screened first. Regions
with one or more SNP “no calls” in the absence of at least ten
consecutive homozygous SNPs were not considered, since the
presence  of  heterozygous  genotypes  for  the  failed  SNPs
cannot be excluded. In such cases, if the genotypes within the
corresponding region were confirmed in one of the affected
siblings in a family, that genomic region was considered a
candidate. Selected homozygous regions were reconfirmed by
genotyping microsatellite markers within the interval in the
respective  families.  These  regions  were  evaluated  on  the
ABI3130 XL platform using GeneScan software (Applied
Biosystems Inc., Palo Alto, CA).
Candidate  gene  screening:  Known  retinal  disease  genes
localizing to autozygous genomic regions of ARRP-affected
individuals were screened for pathogenic changes. Coding
regions  were  PCR-amplified  and  directly  sequenced  to
identify any changes. Pathogenicity of sequence changes was
further  confirmed  with  cosegregation  analysis  in  family
members  and  in  100  unrelated  normal  controls  of  Indian
origin.  Controls  were  recruited  locally  and  were  mostly
southern Indian in origin. Missense changes were evaluated
with  multiple  sequence  alignments  using  NCBI  BLAST
(Basic  Local  Alignment  Search  Tool),  SIFT  (Sorting
Intolerant  From  Tolerant)  [9],  and  Polymorphism
Phenotyping (PolyPhen) [10] to predict the impact on the
protein.
RESULTS
Twenty-six families were included in the study, of which 23
were consanguineous. All families were from southern India.
Following  genome-wide  SNP  genotyping  of  affected
members of 26 families, homozygous segments of ten or more
consecutive SNPs shared between affected individuals of each
family were shortlisted for candidate gene evaluation. There
were  several  such  homozygous  segments  in  each  family,
ranging from one to 18 in the families studied (Table 1), with
an average of about nine homozygous segments per family.
The  sizes  in  megabases  of  the  regions  defined  by  >ten
consecutive SNPs ranged from 1 to 45 Mb. Affected members
of 16 out of 26 families were found to have homozygous
regions in their genome harboring one or more of 18 different
genes  for  recessive  RP.  These  genes  were  evaluated  for
possible pathogenic changes in relevant families. Pathogenic
mutations were identified in three different genes in three
families. The details of the remaining 23 families, including
the number of autozygous regions found in each family and
the known genes if any tested in each family, are summarized
in Table 1.
The TULP1 and MFRP genes mapped to the homozygous
regions in one family each, and the NR2E3 gene mapped to
homozygous regions in three out of 26 families. Screening of
these genes revealed novel pathogenic mutations in the three
families, one each with mutations in TULP1, NR2E3, and
MFRP. Each mutation was confirmed for cosegregation in
family members (parents and siblings) as well as for absence
in 100 unrelated normal controls. The mutations described
here were absent in the control population.
TULP1 gene: The TULP1 gene was screened in Family
A (Figure 1A) due to the presence of homozygosity at this
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1167locus extending to 8.1 Mb. A homozygous missense change
c.1047T>G  (NM_003322.3)  was  detected  in  two  affected
individuals,  corresponding  to  Asn349Lys  (Figure  1B).  A
blood  sample  was  not  collected  from  one  of  the  affected
individuals  as  the  patient  was  mentally  challenged.  The
unaffected  parents  were  carriers  of  the  mutation.  This
mutation was not found in 100 unrelated normal controls. The
Asn349 residue is located in the conserved C-terminal tubby
domain. Multiple sequence alignment of the protein shows
that this residue is highly conserved (Figure 1C). Analysis of
the substitution with the SIFT and PolyPhen tools predicted
that the change is probably damaging to the protein.
Clinical features: The affected members in this family
had a history of onset of poor vision with night vision worse
than daytime vision before ten years of age (Table 2). Two of
the affected children reportedly had visual defects before the
age  of  one  year  according  to  the  parents.  The  patients
complained of difficulties in day and night vision. They had
slowly progressive vision loss. Fundus evaluation showed
RPE degeneration, arterial narrowing, pigmentary deposits,
and  disc  pallor.  In  addition,  cellophane  reflexes  from  the
macula were observed. There was diffuse loss of visual fields.
Scotopic and photopic flash ERG was extinguished in one
patient,  and  visual  acuity  was  about  20/100.  In  the  other
patient, ERG was not performed. Clinically, the patients had
typical RP with the onset at an early age and progressive
disease. The fundus photographs of one patient in this family
are shown in Figures 1D,E.
NR2E3 gene: Affected members of three families had
homozygous segments mapping to the chromosome 15 region
of  41  Mb,  28  Mb,  and  9.5  Mb.  The  largest  homozygous
segment of 41 Mb included the NR2E3 and RLBP1 genes
present in Family B (Figure 2A). Screening of the coding
regions of NR2E3 and RLBP1 genes in the respective families
showed a homozygous complex mutation in Family B that
consisted of a deletion of GC at codon 48 (exon 2) with the
insertion of 25 bp (c.143–144delGCins25; NM_014249.2;
Figure 2B). The mutation predicts a frameshift at codon 48
with 65 amino acids of the altered reading frame followed by
a premature termination codon. This mutation was present in
both affected siblings and was heterozygous in both parents.
The remaining unaffected sibling was not available for the
study.  This  mutation  was  absent  in  100  unrelated  normal
controls. No mutations in NR2E3 or RLBP1 were found in the
remaining two families.
Clinical features: The two affected individuals in Family
B had initial symptoms of decreased night vision with onset
of disease in the first few years of life (Table 2). The fundus
showed features of an atypical retinal dystrophy with white
flecks in the periphery and gliotic scars in the posterior pole
(Figure 2C). ERGs were of the rod-cone type. The condition
of the ERG and clinical features were highly suggestive of an
enhanced  S-cone  syndrome  (ESCS)  phenotype  [11].
However, ESCS could not be confirmed as the patient did not
undergo optical coherence tomography for macula schisis. In
addition, the gliotic scars observed were unusual.
MFRP gene: This gene was screened in Family C (Figure
3A) due to the presence of an 8.5 Mb homozygous region on
chromosome 11 that included the MFRP gene locus. All three
affected had a single base deletion in exon 5, c.498delC, at
codon 166 of the protein (Pro166ProfsX26; NM_031433.2;
Figure  3B).  The  parents  were  heterozygous  carriers.
Screening  of  100  unrelated  normal  controls  showed  this
change was absent in the control population. The frameshift
resulting  from  this  deletion  leads  to  termination  after  25
residues.
Clinical features: The three affected individuals showed
the onset of symptoms very early in life noted from childhood
at about ten years or younger, based on the history of visual
defects  reported  by  the  patients.  The  individuals  had
progressive diminution of night vision. The fundus showed
some degree of arterial narrowing, disc pallor, and confluent
RPE degeneration including perifoveal pigments (Table 2;
Figure  3C).  The  bright  flash  ERGs  were  sub-normal  and
severely diminished with a rod-cone pattern. Clinically, all the
patients had atypical RP wherein the younger two affected
siblings (C2 and C3 in Table 2) had fewer pigments with high
hyperopia of +11 and +13 diopters, respectively. The oldest
sibling  (C1)  had  slightly  more  pigments  and  macular
involvement than the others.
DISCUSSION
The results described in this study identify mutations in ARRP
genes in families of Indian origin. These data add to and
expand on our previous studies on ARRP [8,12]. Identifying
potential disease loci by homozygosity mapping particularly
for a heterogeneous disorder is facilitated by SNP arrays due
to the rapidity with which whole genome analysis is possible.
This approach has resulted in known and novel genes for
ARRP being detected in previous studies [13-15]. We found
16 families had loci mapping known ARRP or related retinal
dystrophy genes, and screening of these revealed mutations in
three families. This is approximately one-fifth of the families
screened for mutations in known genes. The disease locus
could map to any of the other homozygous regions mapped in
the  rest  of  the  cases.  Since  the  families  involved  are  not
suitable  for  linkage  analysis,  one  cannot  assess  the
significance of the homozygous regions detected here. Rather,
this approach provides plausible candidates for testing and
may help narrow the potential loci to be screened in a subset
of families. In the presence of a high degree of consanguinity,
one would also expect a higher prevalence of homozygosity
in the genome in such families [3].
The TULP1 mutation of Asn349Lys is located in the
conserved tub domain extending between residues 298 and
536  of  TULP1  (AAB53700.1)  and  is  associated  with  a
Molecular Vision 2012; 18:1165-1174 <http://www.molvis.org/molvis/v18/a122> © 2012 Molecular Vision
1168Figure 1. Details of ARRP patient from Family A with a mutation in the TULP1 gene. A: Pedigree shows affected (dark symbols) and unaffected
(open) symbols, with squares representing men and circles representing women. A double line connecting spouses denotes consanguinity.
B: Sequence chromatogram of the TULP1 gene in normal control (top) and in patient A-1 (bottom) with homozygous mutation T>G (arrows),
resulting in a codon change AAT (Asn) to AAG (Lys). The protein sequence alignment of TULP1 from different species (C) shows conservation
of the Asn349 residue. Fundus photograph of right (D) and left (E) eyes of patient A-1 taken at age nine years shows greyish discoloration of
the retina due to widespread RPE atrophy, severe arterial narrowing, disc pallor, and cellophane retinopathy due to a thin epiretinal membrane.
Molecular Vision 2012; 18:1165-1174 <http://www.molvis.org/molvis/v18/a122> © 2012 Molecular Vision
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1170Figure 2. Molecular and clinical details of a patient from Family B with a mutation in the NR2E3 gene. A: Pedigree is shown (explanation of
symbols as in Figure 1). B: Sequence of the NR2E3 gene in normal control (top) and patient B2 with homozygous deletion+insertion (bottom).
The dinucleotide undergoing deletion is boxed in top panel. The arrows in the bottom panel mark the inserted sequence. C: Fundus montage
of right eye of patient B-2 (aged 10 years) with NR2E3 mutation showing peripheral graying of retina with white flecks due to RPE atrophy
with macular sparing with hardly any disc or arterial changes. The right temporal retina had unexplained sub-retinal scarring/gliosis and no
obvious bone corpuscular pigment migration at this age.
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1171Figure 3. Molecular and clinical details of patient from Family C with a mutation in the MFRP gene. A: The family pedigree is shown. B:
Sequence of MFRP gene in normal control (top panel) and in patient C-1 (bottom panel). The arrows in the top and bottom panels respectively,
mark the SNP c.492C>T (rs36015759) and the position of the single base deletion in patient C-1. C: Fundus montage of the right eye of patient
C-1 (aged 21 years) from Family C with an MFRP gene mutation showing perifoveal pigment deposits, relative parafoveal sparing, diffuse
extensive graying of retina with white flecks extending from arcades to the peripheral retina, and the presence of a peripheral reticular, bone
corpuscular type of pigmentary retinopathy. There is not much disc pallor or arterial narrowing.
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1172phenotype of early-onset retinal dystrophy with onset at one
and  eight  years  for  two  patients  in  the  family  (Table  2).
Notable features included nyctalopia in early stages, early
macular involvement in one of the siblings, and bright macular
reflexes in both cases. The presence of macular involvement
was also a feature of patients with a mutation in TULP1
reported in our earlier study [12]. Contrary to reports in the
literature in which nystagmus was a feature of patients with
TULP1 mutations [3,15,16], no nystagmus was present in our
patients. Other clinical features were characteristic of RP.
The complex novel mutation in NR2E3 detected in our
study predicts a frameshift in the N-terminal region of the
protein and hence would be expected to result in complete loss
of activity. Several mutations have been reported in NR2E3
with the majority being missense mutations and only a few
deletions or frameshifts [17]. Mutations in NR2E3 have been
associated with a range of overlapping phenotypes, including
ESCS, clumped pigmentary retinal degeneration, Goldman-
Favre  syndrome,  and  dominant  as  well  as  recessive  RP.
Considerable phenotypic variability is a feature of NR2E3
mutations although features of the NR2E3-linked recessive
disorders include night blindness in early stages, clumped
pigmentary deposits, and a more severe loss of rods than cones
[17]. In addition, the same mutation is reported to be involved
in different phenotypes such as ESCS and ARRP [18,19].
Patients in the present study lacked the more typical features
of RP but had a rod-cone phenotype without the characteristic
clumped pigmentary deposits. The ERGs were of a subnormal
rod-cone type. In addition, notable features seen in our cases
were white flecks in the mid-periphery and sub-retinal scars.
In our patients, the phenotype and ERG were also descriptive
of  ESCS.  However,  the  patient  did  not  undergo  optical
coherence tomography, and we could not confirm the clinical
description of ESCS.
The single base deletion in the MFRP gene observed in
the present study is interesting in that it represents the fifth
independent occurrence of the same mutation reported, in
patients of different countries of origin. The C residue at
position 498 is part of a stretch of seven C residues from c.
492 onwards that represents a mutational hotspot for this gene,
since the mutation at this site has occurred in patients of
different  populations,  including  Mexican  [20,21],  Spanish
[22], and Caucasian [23], and patients from the UK [24].
However, different studies have designated the mutations at
this site differently at DNA as well as protein levels; the c.
492delC [23]and c.498delC [21,22] changes as reported are
not really distinguishable from each other based on the DNA
sequence since it is not clear which C residue among the seven
consecutive ones is undergoing deletion. According to recent
nomenclature guidelines (mutnomen), in case of ambiguity,
the 3′ most position is assigned to have the mutation; hence,
we have described it as c.498delC. Interestingly, one of the
mutations at this site is an insertion of C [20]. Nine distinct
mutations have been reported so far in MFRP associated with
variable  phenotypes.  In  Sundin  et  al.’s  study  [23],  the
phenotype  consisted  of  nanophthalmos,  and  no  retinal
degeneration was observed. In subsequent studies of patients
with MFRP mutations, consistent features frequently reported
are the early onset of visual loss [24], the presence of high
hyperopia,  diminished  ERG  responses  with  a  rod-cone
pattern, and RPE atrophy [20,21]; occasional or inconsistent
features include night blindness, hyperpigmentation of the
retina, foveoschisis, macular cysts, and optic nerve drusen
[22,24]. In the present study, features of RP were seen without
the  other  features  of  MFRP-related  oculopathy.  Affected
siblings in the present study had night blindness, rod-cone
type  of  ERG,  and  extensive  degeneration  of  RPE.  High
hyperopia was observed in this family though variable; the
presence of macular involvement was also variable (Table 2).
In summary, the data presented here demonstrate the role
of the TULP1, MFRP, and NR2E3 genes causing ARRP in
Indian families, report novel mutations in these genes, and add
to the range of mutations and clinical phenotypes that have
been documented for this heterogeneous group of disorders.
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